STOCK TITAN

Main Results of 2025 Annual and Extraordinary General Meeting

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Alvotech (ALVO) held its 2025 Annual and Extraordinary General Meeting on June 25, 2025 in Luxembourg. The company announced that all proposed resolutions on the meeting agenda were successfully approved by shareholders. The official notarized meeting minutes and detailed voting results will be made available on the company's investor relations website.

Alvotech (ALVO) ha tenuto la sua Assemblea Generale Annuale e Straordinaria 2025 il 25 giugno 2025 a Lussemburgo. La società ha annunciato che tutte le risoluzioni proposte all'ordine del giorno sono state approvate con successo dagli azionisti. I verbali ufficiali notarili della riunione e i risultati dettagliati delle votazioni saranno resi disponibili sul sito web delle relazioni con gli investitori della società.

Alvotech (ALVO) celebró su Junta General Anual y Extraordinaria 2025 el 25 de junio de 2025 en Luxemburgo. La compañía anunció que todas las resoluciones propuestas en la agenda de la reunión fueron aprobadas con éxito por los accionistas. Las actas oficiales notarizadas de la reunión y los resultados detallados de la votación estarán disponibles en el sitio web de relaciones con inversionistas de la empresa.

Alvotech (ALVO)2025년 6월 25일 룩셈부르크에서 2025년 연례 및 임시 주주총회를 개최했습니다. 회사는 회의 안건에 오른 모든 제안된 결의안이 주주들에 의해 성공적으로 승인되었다고 발표했습니다. 공식 공증된 회의록과 상세한 투표 결과는 회사의 투자자 관계 웹사이트에서 확인할 수 있습니다.

Alvotech (ALVO) a tenu son Assemblée Générale Annuelle et Extraordinaire 2025 le 25 juin 2025 à Luxembourg. La société a annoncé que toutes les résolutions proposées à l'ordre du jour ont été approuvées avec succès par les actionnaires. Le procès-verbal officiel notarié de la réunion ainsi que les résultats détaillés des votes seront disponibles sur le site web des relations investisseurs de l'entreprise.

Alvotech (ALVO) hielt am 25. Juni 2025 in Luxemburg seine ordentliche und außerordentliche Hauptversammlung 2025 ab. Das Unternehmen gab bekannt, dass alle auf der Tagesordnung stehenden Beschlussvorschläge von den Aktionären erfolgreich genehmigt wurden. Das offiziell notariell beglaubigte Sitzungsprotokoll sowie detaillierte Abstimmungsergebnisse werden auf der Investor-Relations-Website des Unternehmens veröffentlicht.

Positive
  • None.
Negative
  • None.

The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg, Grand Duchy of Luxembourg. 

All of the draft resolutions on the 2025 AGM agenda were approved. Notarized meeting minutes and voting results will be published on the Company’s special web portal for the 2025 Annual General Meeting at:

https://investors.alvotech.com/corporate-governance/annual-general-meeting-2025

Alvotech Investor Relations
Benedikt Stefansson
alvotech.ir@alvotech.com


FAQ

When and where was Alvotech's (ALVO) 2025 Annual General Meeting held?

Alvotech's 2025 Annual General Meeting was held on June 25, 2025 at Arendt House, 41A Avenue John F. Kennedy in Luxembourg.

What were the results of Alvotech's (ALVO) 2025 AGM?

All draft resolutions presented on the 2025 AGM agenda were approved by shareholders.

Where can investors find the detailed voting results of Alvotech's 2025 AGM?

The notarized meeting minutes and voting results will be available on Alvotech's investor portal at investors.alvotech.com under the Corporate Governance section.

Who should investors contact for more information about Alvotech's 2025 AGM?

Investors can contact Benedikt Stefansson from Alvotech Investor Relations at alvotech.ir@alvotech.com.
Alvotech

NASDAQ:ALVO

ALVO Rankings

ALVO Latest News

ALVO Stock Data

2.79B
72.97M
64.88%
6.26%
0.17%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Luxembourg
Luxembourg